Lingyan Lv
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- RNA Interference and Gene Delivery 10
- Pluripotent Stem Cells Research 2
- Extracellular vesicles in disease 2
- Advanced biosensing and bioanalysis techniques 2
-
- Nanoparticle-Based Drug Delivery 8
- Co-authors
- Hongliang Xin (14 shared papers)Wei Lv (9 shared papers)Qunwei Xu (7 shared papers)Yan Jiang (7 shared papers)Yue Zhao (6 shared papers)Zhongyuan Wang (5 shared papers)Baoyan Wang (5 shared papers)Lin Wu (2 shared papers)
- Journals
- Journal of Controlled Release (3 papers)Scientific Reports (2 papers)Drug Delivery (1 paper)European Heart Journal (1 paper)Biomaterials (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lingyan Lv
23 papers receiving 780 citations
Peers
Comparison fields: 5 of 91
- Biomaterials 347
- Neurology 88
- Pharmaceutical Science 52
- Biomedical Engineering 259
- Developmental Neuroscience 22
Countries citing papers authored by Lingyan Lv
This map shows the geographic impact of Lingyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Lv more than expected).
Fields of papers citing papers by Lingyan Lv
This network shows the impact of papers produced by Lingyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Lv. The network helps show where Lingyan Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 130 | |
| 2 | 2015 | 103 | |
| 3 | 2014 | 69 | |
| 4 | 2022 | 64 | |
| 5 | 2016 | 59 | |
| 6 | 2015 | 53 | |
| 7 | 2022 | 47 | |
| 8 | 2019 | 40 | |
| 9 | 2017 | 38 | |
| 10 | 2022 | 29 | |
| 11 | 2022 | 28 | |
| 12 | 2016 | 26 | |
| 13 | 2020 | 23 | |
| 14 | 2023 | 17 | |
| 15 | 2014 | 16 | |
| 16 | 2021 | 15 | |
| 17 | 2022 | 11 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 4 | |
| 20 | 2015 | 4 |
About Lingyan Lv
Lingyan Lv is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Immunology and Surgery, having authored 24 papers that have together received 785 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (5 papers), Pluripotent Stem Cells Research (2 papers), Extracellular vesicles in disease (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Reproductive Biology and Fertility (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Biomaterials (347 citations), Neurology (88 citations), Pharmaceutical Science (52 citations), Biomedical Engineering (259 citations) and Developmental Neuroscience (22 citations). Lingyan Lv has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hongliang Xin, Wei Lv, Qunwei Xu, Yan Jiang, Yue Zhao, Zhongyuan Wang, Baoyan Wang, Lin Wu, Shengnan Li and Xiuzhen Wang. Their work appears in journals such as Journal of Controlled Release, Scientific Reports, Drug Delivery, European Heart Journal and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.